Including Quantitative Benefit‐Risk Assessment in Seamless Phase 2/3 Designs With Dose Selection

Marco Ratta, Donia Skanji, Zhaoyang Teng, Gaëlle Saint‐Hilary, Mauro Gasparini, Pavel Mozgunov
Statistics in Medicine · Wiley · 2026-11-17 · DOI: 10.1002/sim.70790

Аннотация

Statistics in Medicine, Volume 45, Issue 25-27, November 2026.

Читать у издателя →

Похожие статьи